At first glance, this study on rodents and analysis centered on women may not seem relevant to male bodybuilders. However, bear with me - the findings contained within suggest it may be mechanistically applicable to both male and female populations.
The theory being developed here suggests that persistently elevated LH levels - such as happens in primary hypogonadism as a result of AAS, and as is intentionally recreated by men during PCT with SERMs - may be partially responsible for a decline in cognition, reduction in spinal nerve density, and subsequent onset of Alzheimer's Disease, independently of altered oestrogen levels (which research already suggests to be neuroprotective in AAS-using bodybuilders).
To quote from the study:
What we are starting to understand is that hormones like LH/FSH are not merely passive gonadal signalling mechanisms, but instead may be far more important to our general state of health (both physical and mental) than previously appreciated. Thus persistent elevations in their levels due to hypogonadism may be harmful and not helpful, especially in the presence of lowered sex hormone levels.
For any bodybuilder, but especially those who've risked doing blast-cruise or high-dose cycles for long periods, subsequent abnormally low test/E2 levels and elevated LH/FSH may thus be a portent of an increased risk of long-term neurological damage.
Clearly more research is needed before we can begin to draw anything like firm conclusions, but it's yet another indication that the insensible and/or abusive use of AAS may be leading to further unintended long-term harms that nobody is discussing.
Study:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718885/
The theory being developed here suggests that persistently elevated LH levels - such as happens in primary hypogonadism as a result of AAS, and as is intentionally recreated by men during PCT with SERMs - may be partially responsible for a decline in cognition, reduction in spinal nerve density, and subsequent onset of Alzheimer's Disease, independently of altered oestrogen levels (which research already suggests to be neuroprotective in AAS-using bodybuilders).
To quote from the study:
Independent of the ability of estrogens to regulate cognitive and neuronal function, increasing data support a role for LH on cognition. In this regard, serum LH levels are higher in Alzheimer’s disease (AD) patients (Short et al. 2001; Butchart et al., 2012), are associated with increased AD pathology in men (Verdile et al. 2008; Verdile et al., 2014) and cognitive dysfunction in older women (Rodrigues et al. 2008). In rodents, pharmacologically lowering LH levels with leuprolide acetate, a GnRHR super-agonist, is as effective as E2 replacement at improving cognitive function in ovariectomized mice (Bryan et al., 2010) as well as in AD models (Casadesus et al., 2006, Palm et al. 2014). Benefits of reducing serum LH levels on cognition have also been shown using the classic GnRHR antagonists such as antide in male and female rats (Ziegler et al. 2010, McConnell et al. 2012) and cetrorelix in rats and mice (Telegdy et al., 2009; Telegdy et al., 2010). Given the different mechanism of action of these drugs, but common end result (i.e. lowering LH levels), this suggests that peripheral LH rather than GnRHR signaling is associated with cognitive benefits.
What we are starting to understand is that hormones like LH/FSH are not merely passive gonadal signalling mechanisms, but instead may be far more important to our general state of health (both physical and mental) than previously appreciated. Thus persistent elevations in their levels due to hypogonadism may be harmful and not helpful, especially in the presence of lowered sex hormone levels.
For any bodybuilder, but especially those who've risked doing blast-cruise or high-dose cycles for long periods, subsequent abnormally low test/E2 levels and elevated LH/FSH may thus be a portent of an increased risk of long-term neurological damage.
Clearly more research is needed before we can begin to draw anything like firm conclusions, but it's yet another indication that the insensible and/or abusive use of AAS may be leading to further unintended long-term harms that nobody is discussing.
Study:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718885/
Last edited: